Exercise performance: % predicted VO2 max on incremental cardiopulmonary exercise test · adults with asthma
1 finding from 1 review
Change in peak work capacity · idiopathic pulmonary fibrosis
1 finding from 1 review
Change in dyspnoea score · idiopathic pulmonary fibrosis
1 finding from 1 review
Change in quality of life · idiopathic pulmonary fibrosis
1 finding from 1 review
Change in quality of life at long‐term · idiopathic pulmonary fibrosis
1 finding from 1 review
Long‐term survival (incidence of mortality) · idiopathic pulmonary fibrosis
Pulmonary rehabilitation showed no clear difference in long‐term survival (incidence of mortality) compared with no pulmonary rehabilitation (low certainty).
1 finding from 1 review
Meters change from baseline in 6MWD · idiopathic pulmonary fibrosis
2 findings from 1 review
Dyspnea · patients with chronic obstructive pulmonary disease
2 findings from 1 review
Functional exercise capacity · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Health‐related quality of life · patients with chronic obstructive pulmonary disease
2 findings from 1 review
Inspiratory muscle strength · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Meters change from baseline in 6MWD · interstitial lung disease
2 findings from 1 review
Change in peak work capacity · interstitial lung disease
1 finding from 1 review
Change in dyspnoea score · interstitial lung disease
1 finding from 1 review
Change in quality of life · interstitial lung disease
1 finding from 1 review
Change in quality of life at long‐term · interstitial lung disease
1 finding from 1 review
Long‐term survival (incidence of mortality) · interstitial lung disease
Pulmonary rehabilitation showed no clear difference in long‐term survival (incidence of mortality) compared with no pulmonary rehabilitation (low certainty).
1 finding from 1 review
Improvement in WHO functional class · pulmonary arterial hypertension
Group 1 Pulmonary arterial hypertension ‐ PDE5i leads to higher improvement in WHO functional class compared with placebo (high certainty).
1 finding from 1 review
Six‐minute walk distance · pulmonary arterial hypertension
1 finding from 1 review
All‐cause mortality · pulmonary arterial hypertension
Group 1 Pulmonary arterial hypertension ‐ PDE5i showed no clear difference in mortality compared with placebo, on combination therapy (moderate certainty).
1 finding from 1 review